Clinical Trial Update: Glutamate Inhibitors in Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial conducted by the University of Zurich is evaluating glutamate inhibitors in patients with glioblastoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Glutamate inhibitors (class)

Snippet

Sponsor: University of Zurich | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING